Dr. Baruch (Boris) Goldstein

Co-Founder & Executive Chairman

With over 20 years' experience in related fields, Dr. Goldstein has built and scaled numerous high-tech and security companies in Silicon Valley and internationally. Dr. Goldstein also brings to MemoryMD over two decades of experience in neuro-net informatics, brain image recognition and processing, artificial intelligence and management of robotic systems.

Vadim Sakharov

President and Chief Technology Officer

CEO of Neurotech and over 15 years of experience in research and applied engineering culminating in over 70 published research papers. Received PhD and BSc from Taganrog State Radiotechnical University.

Jesse W. Crowne

Chief Executive Officer

Mr. Crowne has served as the Chief Executive Officer of Nepetx, LLC, biotechnology start-up company that is developing an enzymatic therapy for celiac disease and non-celiac gluten sensitivity, since January 2016. From January 2016 to March 2017, Mr. Crowne served as the President of Vavotar Life Sciences, LLC, a private clinical stage biotechnology company developing antibody directed oncology products. Mr. Crowne has served as the Vice President of Business Development of Medovex Corp., a publicly-traded company in the business of designing and marketing proprietary medical devices for commercial use in the United States and Europe, since January 2015, and has served as the Executive Co-Chairman of the Board of Directors of Medovex Corp. since February 2, 2018. Mr. Crowne was the founder of Crowne Medical, LLC, a management consulting firm for medical devices and biotech companies, which was founded in December 2013, and was also a Managing Partner at Gorlin Companies, a healthcare focused family office. From April 2010 to June 2014, Mr. Crowne was an associate at White Pine Medical, a subsidiary of Essex Woodlands, which was a private equity investment fund seeking late-stage medical device opportunities.

Nikolay Kukekov

Director

Nickolay V Kukekov, Ph.D. is a Partner at HRA Capital. Prior to forming HRA Capital, Dr. Kukekov was Managing Director of Healthcare Investment Banking at Summer Street Research and, prior to that, was a Co-founder of the Healthcare Investment Banking group at Gilford Securities. Prior to joining Gilford, Dr. Kukekov was a Managing Director at Paramount BioCapital, where he ran the advisory, M&A and capital raising services for in-house private and public portfolio companies. Before that, he was a senior healthcare investment banker at Rodman & Renshaw. His scientific background includes a bachelor degree in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder and a Ph.D. in Neuroscience from Columbia University, College of Physicians and Surgeons in New York. Dr. Kukekov holds a number of research scholarship awards and peer review publications.